文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening.

作者信息

Chan Ngai-Yin, Orchard Jessica, Agbayani Michael-Joseph, Boddington Dean, Chao Tze-Fan, Johar Sofian, John Bobby, Joung Boyoung, Krishinan Saravanan, Krittayaphong Rungroj, Kurokawa Sayaka, Lau Chu-Pak, Lim Toon Wei, Linh Pham Tran, Long Vien Hoang, Naik Ajay, Okumura Yasuo, Sasano Tetsuo, Yan Bernard, Raharjo Sunu Budhi, Hanafy Dicky Armein, Yuniadi Yoga, Nwe Nwe, Awan Zahid Aslam, Huang He, Freedman Ben

机构信息

Princess Margaret Hospital Hong Kong Special Administrative Region China.

Agnes Ginges Centre for Molecular Cardiology Centenary Institute Sydney Australia.

出版信息

J Arrhythm. 2021 Dec 28;38(1):31-49. doi: 10.1002/joa3.12669. eCollection 2022 Feb.

DOI:10.1002/joa3.12669
PMID:35222749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8851593/
Abstract

In this paper, the Asia Pacific Heart Rhythm Society (APHRS) sought to provide practice guidance on AF screening based on recent evidence, with specific considerations relevant to the Asia-Pacific region. A key recommendation is opportunistic screening for people aged ≥65 years (all countries), with systematic screening to be considered for people aged ≥75 years or who have additional risk factors (all countries).

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/49915f4a6916/JOA3-38-31-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/11e23ed10de5/JOA3-38-31-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/9be5f4837ee4/JOA3-38-31-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/8451de256201/JOA3-38-31-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/49915f4a6916/JOA3-38-31-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/11e23ed10de5/JOA3-38-31-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/9be5f4837ee4/JOA3-38-31-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/8451de256201/JOA3-38-31-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/49915f4a6916/JOA3-38-31-g003.jpg

相似文献

[1]
2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening.

J Arrhythm. 2021-12-28

[2]
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.

J Arrhythm. 2021-11-13

[3]
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).

Europace. 2017-11-1

[4]
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).

Thromb Haemost. 2017-12-6

[5]
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.

Thromb Haemost. 2022-1

[6]
2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.

J Arrhythm. 2017-8

[7]
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).

Europace. 2019-2-1

[8]
Prognosis and treatment of atrial fibrillation in Asian cities: 1-year review of the Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry.

Europace. 2022-12-9

[9]
Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.

Eur J Clin Invest. 2022-10

[10]
Letter responding to Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Societad Latinoamericana de Estimulation Cardiaca y Electrofisiologia (SOLAECE).

Europace. 2018-5-1

引用本文的文献

[1]
Knowledge, Attitude, and Practice on Atrial Fibrillation and Atrial Fibrillation Screening in High-Risk Population: A Cross-Sectional Study.

Aging Med (Milton). 2025-7-15

[2]
A comparative review of current international atrial fibrillation guidelines from a primary care perspective.

Malays Fam Physician. 2025-6-7

[3]
Epidemiology of Valvular Heart Disease in Asia Pacific Region.

JACC Asia. 2025-5-3

[4]
Addressing Cardiovascular Diseases Challenges in South Korea: Strategies to Improve Outcomes.

Korean Circ J. 2025-7

[5]
Current Status of Tricuspid Valve Interventions in Asia Pacific Region.

JACC Asia. 2025-3

[6]
Serum Vasoactive Intestinal Peptide as a Novel Biomarker for Low-Voltage Areas in Patients With Atrial Fibrillation.

J Am Heart Assoc. 2025-4

[7]
The burden of atrial fibrillation and unmet needs of its management in Southeast Asia and South Asia.

Lancet Reg Health Southeast Asia. 2025-2-21

[8]
Atrial Fibrillation Screening in the Elderly: A Cost-Effectiveness Analysis for Public Health Policy.

JACC Asia. 2024-11-26

[9]
High-density mapping in catheter ablation for atrial fibrillation in Asia Pacific region: An observational study.

J Arrhythm. 2024-12-18

[10]
Implementing a remote self-screening programme for atrial fibrillation using digital health technology among community-dwellers aged 75 years and older: a qualitative evaluation.

BMJ Open. 2024-10-16

本文引用的文献

[1]
Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial.

Lancet. 2021-10-23

[2]
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial.

Lancet. 2021-10-23

[3]
High-intensity atrial fibrillation screening to prevent stroke.

Lancet. 2021-10-23

[4]
Population screening for atrial fibrillation to prevent stroke.

Lancet. 2021-10-23

[5]
Atrial Fibrillation Detected by Single Time-Point Handheld Electrocardiogram Screening and the Risk of Ischemic Stroke.

Thromb Haemost. 2022-2

[6]
World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update.

Glob Heart. 2021-5-27

[7]
Validation of Adhesive Single-Lead ECG Device Compared with Holter Monitoring among Non-Atrial Fibrillation Patients.

Sensors (Basel). 2021-4-30

[8]
Comparison between a 6‑lead smartphone ECG and 12‑lead ECG in athletes.

J Electrocardiol. 2021

[9]
Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: A prospective multi-centre study.

Int J Cardiol Heart Vasc. 2021-1-12

[10]
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation.

Can J Cardiol. 2020-12

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索